MSB 1.03% 98.0¢ mesoblast limited

CDC issues new Opioid guidlines, page-7

  1. 597 Posts.
    lightbulb Created with Sketch. 302
    For those interested in another opioid crisis play MVP's green whistle is a good example of non opioid analgesic selling in so many countries around the world except usa where the fda put it on clinical hold and so now they are redesigning the phase 3. usa approval might be a few years away but could also be right place right time with these new guidelines. non holder just thought it was relevant to this topic.
    reverse commercialisation strategy to us. usa last, and all the approvals and evidence in other countries means nothing to the fda. some holders here have suggested the same strategy. can't say i agree.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
0.010(1.03%)
Mkt cap ! $1.107B
Open High Low Value Volume
96.0¢ 99.0¢ 95.5¢ $3.454M 3.540M

Buyers (Bids)

No. Vol. Price($)
28 84546 97.5¢
 

Sellers (Offers)

Price($) Vol. No.
98.0¢ 132684 16
View Market Depth
Last trade - 13.35pm 27/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.